FRE.AX

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Drug Manufacturers - General

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
FRE.AXFirebrick Pharma Limited	$0.03	+0.00%	$7M	—
AGH.AXAlthea Group Holdings Limited	$0.02	-4.76%	$17M	—
AVE.AXAvecho Biotechnology Limited	$0.02	-4.76%	$77M	—
BTC.AXBTC Health Limited	$0.06	+0.00%	$21M	—
IMC.AXImmuron Limited	$0.04	-13.73%	$11M	—
IME.AXImExHS Limited	$0.33	+0.00%	$18M	—
MDR.AXMedAdvisor Limited	$0.02	+0.00%	$14M	—

Source: Financial Modeling Prep · peers by sector/industry

Firebrick Pharma Limited

Firebrick Pharma Limited, an enterprise established in 2012 and headquartered in Melbourne, Australia, is dedicated to the research, development, and market launch of Nasodine, a nasal spray treatment for the common cold, exclusively for the Australian market.

www.firebrickpharma.com

Employees: 6
IPO / List date: Jan 27, 2022
HQ: AU

Held by traders on TradeandTell

No one on the platform currently holds FRE.AX.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in FRE.AX as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded FRE.AX yet.